Telix Pharmaceuticals Limited (TLX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 | Q4'21 | Q2'21 | Q4'20 | Q2'20 | Q4'19 | Q2'19 | Q4'18 | Q2'18 | Q4'17 | Q2'17 |
|---|
| Sales/Revenue | 620.44M | 593.11M | 594.24M | 188.96M | 281.71M | 220.83M | 136.05M | 24.05M | 4.69M | 2.91M | 3.61M | 1.61M | 1.67M | 1.82M | 195K | 0 | 0 | 0 |
| Revenue Growth % | 4.41% | 213.88% | 110.94% | -14.43% | 107.07% | 818.34% | 2803.31% | 726.36% | 29.95% | 81.08% | 116.25% | -11.58% | 755.13% | - | - | - | - | - |
| Cost of Goods Sold | 293.02M | 304.77M | 208.45M | 65.08M | 57.74M | 130.02M | 91.16M | 39.62M | 23.54M | 14.09M | 11.86M | 10.23M | 7.37M | 7.99M | 635.75K | 1.85K | 3.84K | 0 |
| COGS % of Revenue | 47.23% | 51.38% | 35.08% | 34.44% | 20.5% | 58.88% | 67% | 164.76% | 502.43% | 484.06% | 328.87% | 636.65% | 442.1% | 439.5% | 326.03% | - | - | - |
| Gross Profit | 327.42M | 288.34M | 385.8M | 123.88M | 223.97M | 90.81M | 44.89M | -15.57M | -18.86M | -11.18M | -8.25M | -8.62M | -5.7M | -6.17M | -440.75K | -1.85K | -3.84K | -52.58K |
| Gross Margin % | 52.77% | 48.62% | 64.92% | 65.56% | 79.5% | 41.12% | 33% | -64.76% | -402.43% | -384.06% | -228.87% | -536.65% | -342.1% | -339.5% | -226.03% | - | - | - |
| Gross Profit Growth % | -15.13% | 132.76% | 72.25% | 36.42% | 398.93% | 683.17% | 338.05% | -39.33% | -128.5% | -29.59% | -44.67% | -39.76% | -1194.28% | -333078.4% | -11377.86% | 96.48% | - | - |
| Operating Expenses | 317.6M | 272.56M | 317.42M | 110.13M | 203.9M | 59.37M | 54.59M | 47.92M | 31.06M | 20.42M | 20.89M | 11.48M | 18.37M | 10.01M | 17.38M | 10.46M | 4.18M | 1.58M |
| OpEx % of Revenue | 51.19% | 45.95% | 53.42% | 58.28% | 72.38% | 26.89% | 40.13% | 199.28% | 662.78% | 701.86% | 579.34% | 714.69% | 1101.44% | 551% | 8911.79% | - | - | - |
| Selling, General & Admin | 183.04M | 146.92M | 111.82M | 95.3M | 69.8M | 28.93M | 64.02M | 23.08M | 10.59M | 6.75M | 16.33M | 2.73M | 4.9M | 6.54M | 5.14M | 4M | 1.97M | 774.63K |
| SG&A % of Revenue | 29.5% | 24.77% | 18.82% | 50.44% | 24.78% | 13.1% | 47.06% | 95.97% | 226.06% | 232.1% | 452.8% | 169.77% | 294% | 359.98% | 2635.81% | - | - | - |
| Research & Development | 134.56M | 123.96M | 75.25M | 45.78M | 98.4M | 30.45M | 33.01M | 24.84M | 20.46M | 13.67M | 14.48M | 8.61M | 13.32M | 7.84M | 12.24M | 6.45M | 2.2M | 801.91K |
| R&D % of Revenue | 21.69% | 20.9% | 12.66% | 24.23% | 34.93% | 13.79% | 24.27% | 103.31% | 436.73% | 469.76% | 401.55% | 535.47% | 798.94% | 431.35% | 6275.98% | - | - | - |
| Other Operating Expenses | 0 | 1000K | 1000K | -1000K | 1000K | 0 | -1000K | 0 | 0 | 0 | -1000K | 151.85K | 141.83K | -1000K | 0 | 0 | 0 | 0 |
| Operating Income | 9.82M | 15.79M | 68.38M | 13.75M | -15.6M | 31.44M | -9.7M | -63.49M | -49.92M | -31.6M | -29.14M | -20.11M | -24.07M | -16.18M | -17.19M | -10.46M | -3.37M | -1.58M |
| Operating Margin % | 1.58% | 2.66% | 11.51% | 7.28% | -5.54% | 14.24% | -7.13% | -264.04% | -1065.22% | -1085.91% | -808.21% | -1251.34% | -1443.55% | -890.5% | -8814.39% | - | - | - |
| Operating Income Growth % | -85.63% | 14.79% | 538.38% | -56.26% | -60.74% | 149.51% | 80.56% | -100.93% | -71.27% | -57.14% | -21.07% | -24.25% | -40.05% | -54.75% | -410.6% | -563.41% | - | - |
| EBITDA | 27.71M | 26.45M | 72.7M | 17.41M | -13.51M | 34.72M | -7.05M | -60.76M | -47.29M | -28.79M | -26.6M | -17.77M | -22.16M | -13.86M | -17.18M | -10.46M | -3.36M | 1.58M |
| EBITDA Margin % | 4.47% | 4.46% | 12.23% | 9.21% | -4.79% | 15.72% | -5.18% | -252.65% | -1009.13% | -989.18% | -737.58% | -1106.04% | -1328.84% | -762.67% | -8811.79% | - | - | - |
| EBITDA Growth % | -61.88% | 51.94% | 638.26% | -49.86% | -91.68% | 157.15% | 85.1% | -111.06% | -77.79% | -61.95% | -20.03% | -28.23% | -28.96% | -32.56% | -411.03% | -763.29% | - | - |
| D&A (Non-Cash Add-back) | 17.89M | 10.67M | 4.32M | 3.66M | 2.09M | 3.29M | 2.66M | 2.74M | 2.63M | 2.81M | 2.55M | 2.33M | 1.91M | 2.32M | 5.07K | 1.93K | 3.84K | 3.15M |
| EBIT | 11.03M | -1.76M | 78.46M | 36.63M | 19.2M | -11.86M | -27.65M | -70.56M | -61.89M | -36.69M | -34.22M | -24.86M | -24.35M | -16.06M | -17.19M | -10.46M | -4.18M | -1.58M |
| Net Interest Income | -8.36M | -3.92M | -6.27M | -4.33M | 18K | 11K | -54K | -137K | -15K | -11K | -921K | -187K | -1.3M | -1.01M | -437.12K | 740.86K | 6.57K | 35.01K |
| Interest Income | 3.32M | 3.62M | 10.25M | 610K | 566K | 453K | 214K | 1K | 89K | 74K | 19K | 48K | 41.58K | 56.42K | 164.88K | 167.87K | 13.82K | 39.71K |
| Interest Expense | 11.68M | 3.92M | 16.52M | 4.94M | 548K | 442K | 268K | 138K | 104K | 85K | 940K | 235K | 1.34M | 1.06M | 602K | -572.98K | 7.25K | 4.7K |
| Other Income/Expense | -10.47M | -23.13M | -21.46M | -4.61M | 30.98M | -43.74M | -18.21M | -7.21M | -12.08M | -5.45M | -6.01M | -4.99M | -1.62M | -940.55K | 6.66M | 0 | 132.12K | 5.05K |
| Pretax Income | -645.3K | -7.35M | 46.91M | 9.14M | 15.39M | -12.3M | -27.92M | -70.7M | -61.99M | -37.05M | -35.16M | -25.1M | -25.69M | -17.13M | -10.52M | -5.19M | -3.23M | -1.57M |
| Pretax Margin % | -0.1% | -1.24% | 7.89% | 4.84% | 5.46% | -5.57% | -20.52% | -294.02% | -1322.94% | -1273.06% | -974.96% | -1561.67% | -1540.61% | -942.25% | -5396.92% | - | - | - |
| Income Tax | 6.61M | 3.87M | 8.67M | -2.54M | -4.14M | 2.02M | 5.27M | 188K | -14M | -4.53M | -8.57M | -6.79M | -8.19M | -6.76M | -1.88M | -68 | 0 | 0 |
| Effective Tax Rate % | -1023.95% | -52.61% | 18.49% | -27.75% | -26.93% | -16.42% | -18.87% | -0.27% | 22.58% | 12.23% | 24.38% | 27.08% | 31.89% | 39.45% | 17.9% | 0% | 0% | 0% |
| Net Income | -7.25M | -3.48M | 38.24M | 11.68M | 19.53M | -14.32M | -33.19M | -70.89M | -48M | -32.51M | -26.59M | -18.3M | -17.5M | -10.37M | -8.64M | -5.19M | -4.81M | -3.14M |
| Net Margin % | -1.17% | -0.59% | 6.43% | 6.18% | 6.93% | -6.48% | -24.39% | -294.8% | -1024.24% | -1117.32% | -737.27% | -1138.83% | -1049.33% | -570.54% | -4430.77% | - | - | - |
| Net Income Growth % | -118.97% | -129.82% | 95.79% | 181.56% | 158.85% | 79.8% | 30.85% | -118.03% | -80.53% | -77.66% | -51.94% | -76.49% | -102.52% | -99.8% | -79.79% | -65.13% | - | - |
| Net Income (Continuing) | -7.25M | -3.48M | 38.24M | 29.37M | 19.53M | -14.32M | -33.19M | -70.89M | -48M | -32.51M | -26.59M | -18.3M | -17.5M | -10.37M | -8.64M | -5.19M | -3.23M | -1.57M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.02 | -0.01 | 0.11 | 0.03 | 0.06 | -0.05 | -0.10 | -0.23 | -0.17 | -0.12 | -0.10 | -0.07 | -0.07 | -0.05 | -0.04 | -0.03 | -0.02 | -0.02 |
| EPS Growth % | -119.45% | -130.93% | 82.42% | 173.84% | 160.3% | 80.39% | 41.18% | -91.67% | -70% | -66.2% | -39.08% | -52% | -72.01% | -80.61% | -120% | -6.91% | - | - |
| EPS (Basic) | -0.02 | -0.01 | 0.12 | 0.03 | 0.06 | -0.05 | -0.10 | -0.23 | -0.17 | -0.12 | -0.10 | -0.07 | -0.07 | -0.05 | -0.04 | -0.03 | -0.02 | -0.02 |
| Diluted Shares Outstanding | 338.78M | 337.2M | 345.19M | 350.75M | 323.73M | 317.62M | 316.34M | 307.33M | 283.02M | 281.02M | 259.95M | 253.48M | 243.39M | 218.37M | 206.81M | 197.44M | 253.52M | 127.99M |
| Basic Shares Outstanding | 338.78M | 337.21M | 331.23M | 334.23M | 323.73M | 317.62M | 316.34M | 307.33M | 283.02M | 281.02M | 259.95M | 253.48M | 243.39M | 218.37M | 206.52M | 197.44M | 253.52M | 127.99M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |